Skip to main content

Table 1 Patient demographics

From: Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study

  Dex (−) (n = 6) Dex 1 day (n = 12) Dex multiday (n = 6)
Age (year) 67.3 (58–73) 67.0 (57–79) 69.5 (57–76)
Sex (male/female) 5/1 12/0 3/3
PS (0/1/2) 5/1/0 10/1/1 6/0/0
Body surface area (m2) 1.8 (1.5–2.0) 1.7 (1.5–1.8) 1.6 (1.4–1.8)
BMI (kg/m2) 22.9 (19.8–28.1) 21.2 (15.9–27.5) 24.7 (19.3–30.0)
Creatinine clearance (mL/min) 94.5 (62.3–125.1) 99.8 (55.6–143.7) 98.5 (65.9–143.8)
Total bilirubin (mg/dL) 0.53 (0.4–0.8) 0.63 (0.3–1.4) 0.72 (0.5–1.3)
AST (IU/L) 24.7 (12–31) 22.0 (10–32) 18.3 (15–21)
Concomitant medications
 Oral 5HT3 receptor antagonists (%) 83.3 33.3 100
 Dopamine antagonists (%) 50 33.3 50
 Drugs reported leucopenia (%) 50 41.7 33.3
 Purgative medicine (%) 50 50 50
  1. Data are mean values (range in parentheses)
  2. PS performance status, AST aspartate transaminase, 5HT serotonin, BMI body mass index